NCT01515969 2016-07-12
Phase 1 Erlotinib and Dovitinib (TKI258) in Advanced Non-small Cell Lung Cancer (NSCLC)
Stanford University
Phase 1 Terminated
Clinical Trials
7 trialsNCT00633724 2013-08-15
Multiple-Vaccine Therapy in Treating Patients With Non-small Cell Lung Cancer
Fukushima Medical University
Phase 1 Completed
NCT00874588 2013-08-15
Peptide Vaccine Targeting to Cancer Specific Antigen Combined With Anti-angiogenic Peptide Antigen in Treating Patients With Non-small Cell Lung Cancer
Fukushima Medical University
Phase 1 Completed
NCT00632333 2011-07-21
Combination of Chemoradiation Therapy and Epitope Peptide Vaccine Therapy in Treating Patients With Esophageal Cancer
Teikyo University
Phase 1 Unknown
NCT01266707 2010-12-24
Antiangiogenic Peptide Vaccine Therapy in Treating Patient With Hepatocellular Carcinoma
Fukushima Medical University
Phase 1 Unknown
NCT01266720 2010-12-24
HLA-A*0201 Restricted Peptide Vaccine Therapy With Gemcitabine With Gemcitabine in Patient Pancreatic Cancer (Phase1)
Fukushima Medical University
Phase 1 Unknown
NCT00561275 2008-07-15
Safety Study of Multiple Peptide Vaccine to Esophageal Cancer
Japanese Foundation for Cancer Research
Phase 1 Completed